The Food and Drug Administration approved a new once-a-day H.I.V. treatment from Gilead Sciences that contains four different drugs in one pill. But the price Gilead plans to charge for the new drug — about $28,500 a year — was criticized as excessive by one AIDS activist, who said it would put additional pressure on [...]